FluidAI Collaborates with Mayo Clinic Platform to Develop AI-Driven Postoperative Monitoring Solutions

FluidAI will utilize Mayo Clinic Platform’s extensive de-identified clinical data to enhance predictive algorithms, aiming to improve patient outcomes in postoperative care.

Kitchener, Ontario— October 28, 2024 — FluidAI Medical (FluidAI), a leader in artificial intelligence (AI)-driven postoperative monitoring, announced a collaboration to access de-identified clinical data through Mayo Clinic Platform_Discover. This collaboration will enable FluidAI to accelerate the development of predictive models aimed at enhancing clinical decision-making and improving patient outcomes.

FluidAI’s StreamTM Platform is a software suite that leverages AI to analyze data from disparate sources to build a comprehensive understanding of the patient’s condition and alert surgeons to potential complications and risks before and after surgery. Stream™ Platform combines data from novel sensors, including FluidAI’s Origin™ sensor platform, with comprehensive and contextualized medical record data to generate insights in real-time that may help physicians predict clinical outcomes.

Mayo Clinic Platform_Discover offers AI solution developers access to diverse, de-identified clinical data, including demographics, diagnoses, imaging, lab results, clinical notes, and pathology reports. This diverse data set enables FluidAI to design predictive models on real-world retrospective data to facilitate faster model development.

“Working with Mayo Clinic Platform_Discover accelerates our ability to develop and validate machine learning models,” says Abdallah El-Falou, CTO of FluidAI. “Clinicians who have experienced the benefits of our work on leak prediction are eager to see how our expanded capabilities will transform postoperative recovery. This collaboration empowers our team of in-house clinicians and data scientists to focus entirely on driving innovation in patient care.” 

This collaboration underscores FluidAI’s commitment to deploying advanced AI-driven solutions in real-world clinical settings, empowering healthcare providers with the tools they need to deliver more precise and effective care. FluidAI’s product’s commercialization efforts are supported by the Critical Technologies Initiative to enhance cybersecurity and AI implementation with contributions from the Government of Ontario’s Ministry of Economic Development, Job Creation and Trade, and Ontario Bioscience Innovation Organization (OBIO).